Lorenzo Veschini

Integrated Multiparametric High-Content Profiling of Endothelial Cells

A. Zamuner, Davide Danovi, Erika Wiseman, 2019, SLAS discovery : advancing life sciences R & D.

Biofunctionalization of bioactive ceramic scaffolds to increase the cell response for bone regeneration

E. Bernardo, P. Brun, M. Dettin, 2021, Biomedical materials.

High content Image Analysis to study phenotypic heterogeneity in endothelial cell monolayers

Davide Danovi, Lorenzo Veschini, F. Chesnais, 2020, bioRxiv.

Hypoxia-inducible transcription factor-1 alpha determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib.

M. Ferrarini, C. Foglieni, Lorenzo Veschini, 2007, Blood.

The vasostatin‐I fragment of chromogranin A inhibits VEGF‐induced endothelial cell proliferation and migration

K. Helle, A. Corti, C. Foglieni, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The vasostatin‐1 fragment of chromogranin A preserves a quiescent phenotype in hypoxia‐driven endothelial cells and regulates tumor neovascularization

C. Doglioni, A. Corti, Lorenzo Veschini, 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Bortezomib induces autophagic death in proliferating human endothelial cells.

M. Ferrarini, C. Foglieni, Lorenzo Veschini, 2010, Experimental cell research.

PHD2 regulates arteriogenic macrophages through TIE2 signalling

K. Alitalo, M. Mazzone, A. Anisimov, 2013, EMBO molecular medicine.

Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity.

P. Carmeliet, J. D’hooge, K. Alitalo, 2012, Cancer cell.